Browsing by Subject "A61P 9/00"

Now showing items 1-8 of 8

    • Cardiac myofibiril induction 
      Lemanski, Larry F.; Arms, Ashley; Kochegarov, Andrei (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2019-09-17)
      Methods and products for altering or promoting the development of heart tissue are disclosed. The methods include the use of nucleic acids of cardiogenic inducing factor for treating a subject having heart disease.
    • Emulsions of perfluoro compounds as solvents for nitric oxide (NO) 
      Garfield, R. E.; Balaban, A. T.; Seitz, W. A. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 1999-02-09)
      The present invention involves perfluoro compound emulsions including nitric oxide, their preparation and their use. These emulsions provide a new source of nitric oxide. Such nitric oxide-containing emulsions may be used ...
    • Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage 
      Prockop, Darwin J.; Lee, Ryanghwa (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-07-31)
      The present invention provides compositions comprising mesenchymal stem cells (MSCs), and methods for their novel use in the repair of cardiac damage and treatment of inflammatory diseases. The invention also provides ...
    • Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative 
      Carney, Darrell H.; Olszewska-pazdrak, Barbara; Fossum, Theresa W. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2012-12-18)
      Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.
    • Polypeptides and polynucleotides from coagulase-negative staphylococci 
      Foster, Timothy J.; Mccrea, Kirk; Hook, Magnus A. O.; Davis, Stacy; Ni Eidhin, Deirdre; Hartford, Orla (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2003-10-21)
      Isolated proteins, designated SdrF, SdrG and SdrH, and their corresponding amino acid and nucleic acid sequences are provided which are useful in the prevention and treatment of infection caused by coagulase-negative ...
    • Polypeptides and polynucleotides from coagulase-negative staphylococci 
      Foster, Timothy J.; Mccrea, Kirk; Hook, Magnus A. O.; Davis, Stacey; Ni Eidhin, Deirdre; Hartford, Orla (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2010-05-04)
      Methods for treating or preventing infections from coagulase-negative staphylococci using proteins and polypeptides from coagulase-negative staphylococcal bacteria such as S. epidermidis, including proteins designated SdrF, ...
    • Proteins and polypeptides from coagulaslase-negative staphylococci 
      Foster, Timothy J.; Mccrea, Kirk; Hook, Magnus A. O.; Davis, Stacy; Nieidhin, Deirdre; Hartford, Orla (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2009-01-06)
      Proteins and polypeptides from coagulase-negative staphylococcal bacteria such as S. epidermidis, including proteins designated SdrF, SdrG and SdrH, and their effective fragments such as their respective A domains, are ...
    • Treatment of stroke using domain V of perlecan 
      Bix, Gregory J. (United States. Patent and Trademark Office; Texas A&M University. Libraries, 2013-06-18)
      The present invention is drawn to methods of stimulating or enhancing angiogenesis in a patient comprising, administering to said patient a therapeutically effective amount of an endorepellin protein, wherein said endorepellin ...